Yes, it's a bit disappointing. Although OSX has held around 4x IPO price and it's only been a couple of months since listing, I was expecting some major announcements in the days and weeks after listing.
I suppose their positive vision statement and outlook as discussed at the recent Bone-Tec conference confirmed what investors already believe, that this is a solid company with great potential. However, nothing new was presented, and much more is needed to propel the share price. Something like an announcement on TGA approval, new contracts or markets opening, a joint venture partner or progress on the long-bone implants that the company is working on.
I bought with a 1-2 year outlook, so I'll be patient for a while. But I would like to see some progress on the PR front, if nowhere else. I'm not impressed by Osteopore's so-called investor relations team, to whom I wrote asking some questions and have yet to get a reply.
OSX Price at posting:
90.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)